Current State of Target Treatment in BRAF Mutated Melanoma

Current State of Target Treatment in BRAF Mutated Melanoma

Incidence of melanoma has been constantly growing during the last decades. Although most of the new diagnoses are represented by thin melanomas, the number of melanoma-related deaths in 2018 was 60,712 worldwide (Global Cancer Observatory, 2019). Until 2011, no systemic therapy showed to improve sur...

Full description

Bibliographic Details
Main Authors: Enrica Teresa Tanda, Irene Vanni, Andrea Boutros, Virginia Andreotti, William Bruno, Paola Ghiorzo, Francesco Spagnolo
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Molecular Biosciences
Subjects:
melanoma
BRAF mutation
targeted therapy
MAPK pathway
metastatic disease
Online Access:https://www.frontiersin.org/article/10.3389/fmolb.2020.00154/full

Internet

https://www.frontiersin.org/article/10.3389/fmolb.2020.00154/full

Similar Items